6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
15m ago	Veradermics Announces Launch of Public Offering
16m ago	New Jersey American Water Proudly Recognizes American Water Charitable Foundation 2026 Water and Environment Grantees
16m ago	Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting
16m ago	37 Capital Adopts Semi-Annual Financial Reporting
16m ago	Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

About

Axsome Therapeutics Inc (NASDAQ:AXSM) — investor relations, events, news, and company updates on 6ix.

Latest News

Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4

Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions

Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms

Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Financials

Revenue

$638.5 M

Market Cap

$8.62 B

EPS

-3.67

Community Chat

Ask AI